No Data
No Data
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Evolus (EOLS) and Becton Dickinson (BDX)
Earnings Preview: Evolus to Report Financial Results Post-market on May 07
Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $25
Press Release: Evolus to Report First Quarter Financial Results on May 7, 2025
Evolus (EOLS) Receives a Buy From Mizuho Securities
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Airbags : looks like positives outweigh the negatives
